Screening-verfahren Für Wirkstoffe Zur Stimulierung Der Humanen Beta-defensine Vom Typ 2 Und/oder Typ 3

  • Published: Feb 24, 2011
  • Earliest Priority: Aug 02 2002
  • Family: 18
  • Cited Works: 21
  • Cited by: 0
  • Cites: 4
  • Additional Info: Cited Works Published
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

The invention relates to active ingredients capable of stimulating direct or indirect expression of type 2 human beta-defensins and/or type 3 human beta-defensins. The invention thus provides an active ingredient capable of stimulating direct or indirect expression of type 2 human beta-defensins and/or type 3 human beta-defensins, characterized in that said active ingredient does not cause any inflammatory, irritation or intolerance reactions. The invention also provides a screening method for the selection of such active ingredients. The invention is applicable to the preparation of cosmetic or pharmaceutical compositions containing such active ingredients.


Claims

Information currently unavailable.

IPC Classifications
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Feb 24, 2011
  • Application: Nov 6, 2002
    DE DE 10251709 A
  • Priority: Nov 6, 2002
    DE DE 10262193 A
  • Priority: Aug 2, 2002
    FR FR 0209905 A

Download Citation


Sign in to the Lens

Feedback